Oil States Enters into New Bank Credit Agreement

Written by Customer Service on February 10, 2021. Posted in Public Companies.

HOUSTON, Feb. 10, 2021 (GLOBE NEWSWIRE) — Oil States International, Inc. (NYSE:OIS) announced today that it has entered into a new $125 million asset-based revolving credit agreement (the “Credit Agreement”). Wells Fargo Bank, National Association is the administrative agent for the Credit Agreement. In addition to Wells Fargo, lenders under the Credit Agreement include Bank of America, National Association, JPMorgan Chase Bank, N.A. and Royal Bank of Canada. Borrowing availability under the Credit Agreement is based on eligible U.S. receivables and inventory. The Credit Agreement replaces Oil States’ existing $200 million revolving credit facility. The maturity date of the Credit Agreement is February 10, 2025.The Credit Agreement contains customary representations, warranties, covenants, terms and conditions...

Newmark Valuation & Advisory to Utilize Altus Group’s Cloud-Enabled ARGUS Enterprise

Written by Customer Service on February 10, 2021. Posted in Public Companies.

TORONTO, Feb. 10, 2021 (GLOBE NEWSWIRE) — Altus Group Limited (“Altus Group”) (TSX: AIF), a leading provider of software, data solutions and independent advisory services to the global commercial real estate (“CRE”) industry, announces that Newmark Valuation & Advisory (“Newmark V&A”), a leading industry innovator, will utilize cloud-enabled ARGUS Enterprise (“AE”), an asset and investment management solution.Through an extensive set of application programming interfaces (“API”) as well as the ability to connect CRE datasets, sources and applications, cloud-enabled AE will provide Newmark V&A a tool to automate complex cash flow reporting requirements, increase efficiencies within the valuation process and deliver analytics to clients.“We are committed to leveraging innovative technology to differentiate our Newmark...

Mesoblast Phase 3 Trial Shows That a Single Injection of Rexlemestrocel-L + Hyaluronic Acid Carrier Results in at Least Two Years of Pain Reduction With Opioid Sparing Activity in Patients With Chronic Low Back Pain Due to Degenerative Disc Disease

Written by Customer Service on February 10, 2021. Posted in Public Companies.

NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced results from the Phase 3 randomized controlled trial of its allogeneic mesenchymal precursor cell (MPC) therapy rexlemestrocel-L in 404 enrolled patients with chronic low back pain (CLBP) due to degenerative disc disease (DDD) refractory to conventional treatments. The results indicate that a single injection of rexlemestrocel-L may provide a safe, durable, and effective opioid-sparing therapy for patients with chronic inflammatory back pain due to degenerative disc disease, and that greatest benefits are seen when administered earlier in the disease process before irreversible fibrosis of the intervertebral disc has occurred.“The durable pain reduction for...

General Cannabis Corp Expands Convertible Financing Round and Adds Additional Capital Partner

Written by Customer Service on February 10, 2021. Posted in Public Companies.

DENVER, Feb. 10, 2021 (GLOBE NEWSWIRE) — General Cannabis Corp (OTCQB: CANN) today announced that it has raised an additional $1.66 million of its senior convertible promissory notes, bringing the total amount raised in the round to $4.6 million. The additional capital will be used to make capital improvements at SevenFive Farm, the Company’s 17,000 square foot light deprivation greenhouse cultivation facility, to extinguish the remainder of its outstanding 15% debt due in 2022 and to provide operating cash.Steve Gutterman, CEO of General Cannabis, stated, “We are pleased to have oversubscribed our convertible note offering, and we are excited to add a new capital partner as another long-term minded, value-added investor. We will deploy these additional funds prudently to continue to build the business and strengthen the balance...

Iterum Therapeutics plc Announces Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares

Written by Customer Service on February 10, 2021. Posted in Public Companies.

DUBLIN, Ireland and CHICAGO, Feb. 10, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the underwriter of its previously announced underwritten public offering of ordinary shares, which closed on February 8, 2021, has exercised in full its option to purchase additional ordinary shares at the public offering price, less underwriting discounts and commissions. After giving effect to the sale of 5,217,391 additional ordinary shares in the option closing, the total number of ordinary shares sold by the Company in the offering increased to 40,000,000 shares, which resulted in aggregate...

Bumble Inc. Prices $2.2 Billion IPO

Written by Customer Service on February 10, 2021. Posted in Public Companies.

AUSTIN, Texas, Feb. 10, 2021 (GLOBE NEWSWIRE) — Bumble Inc. announced today the pricing of its initial public offering of 50,000,000 shares of its Class A common stock at a price to the public of $43.00 per share. Bumble has granted the underwriters a 30-day option to purchase up to an additional 7,500,000 shares of Class A common stock. The shares are expected to begin trading on the Nasdaq Global Select Market on February 11, 2021 under the symbol “BMBL”.Bumble intends to use the proceeds (net of underwriting discounts) from the issuance of 9 million shares to repay a portion of its senior secured term loan facilities and for general corporate purposes, and to bear the expenses of the offering. Bumble intends to use the proceeds (net of underwriting discounts) from the issuance of 41 million shares (or 48.5 million shares if the...

Bitfarms Announces Closing of CAD$40.0 Million Private Placement with U.S. Institutional Investors

Written by Customer Service on February 10, 2021. Posted in Public Companies.

TORONTO and BROSSARD, Québec, Feb. 10, 2021 (GLOBE NEWSWIRE) — Bitfarms Ltd. (“Bitfarms”, or the “Company”) (TSXV:BITF) (U.S.:OTC:BFARF), one of the largest and most productive publicly listed bitcoin mining operations in the world, is pleased to announce that it has closed its previously announced private placement of equity securities (the “Offering”). The Offering was for gross proceeds of approximately CAD$40 million and consisted of the sale of 11,560,695 common shares, along with warrants to purchase an aggregate of up to 11,560,695 common shares, at a purchase price of CAD$3.46 per common share and associated warrant. The warrants have an exercise price of USD$3.01 per common share and exercise period of three and one-half years (through August 12, 2024). The funds were raised via a fully subscribed private placement of units...

Prestige Consumer Healthcare Inc. Announces Upsize and Pricing of $600 Million Senior Notes

Written by Customer Service on February 10, 2021. Posted in Public Companies.

TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige Brands”), has priced an upsized offering of $600 million in aggregate principal amount of 3.750% senior notes due 2031 (the “notes”) in a private offering. The sale of the notes is expected to be completed on or about March 1, 2021, subject to customary closing conditions. The notes will be senior unsecured obligations of Prestige Brands and will be guaranteed by the Company and certain of its domestic subsidiaries.The Company intends to use the net proceeds from the offering, together with cash on hand, to redeem all $600 million of Prestige Brands’ outstanding 6.375% Senior Notes due 2024, and to pay related fees and expenses.The notes...

Delta 9 Provides Guidance & Timing for Year End 2020 Results

Written by Customer Service on February 10, 2021. Posted in Public Companies.

WINNIPEG, Manitoba, Feb. 10, 2021 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to provide guidance on select fourth quarter and year end results ending December 31, 2020 based on preliminary results:The Company anticipates net revenues for the three-month period ending December 31, 2020 to be between $13.7 million and $14.2 million. This compares with:$10.6 million for the same period in 2019, an increase of between 29% and 34%.$13.1 million sequentially from the third quarter of 2020, an increase of between 5% and 8%The Company anticipates revenues for the year ending December 31, 2020 to be between $51.8 million and $52.3 million, compared to $31.8 million for the same period in the prior year.The Company anticipates reporting direct cannabis...

Pilgrim’s Names Matthew Galvanoni Chief Financial Officer

Written by Customer Service on February 10, 2021. Posted in Public Companies.

GREELEY, Colo., Feb. 10, 2021 (GLOBE NEWSWIRE) — Pilgrim’s Pride Corporation (NASDAQ: PPC) announced today that Matthew Galvanoni, an executive with more than 26 years of finance and accounting experience with publicly-traded companies, has joined Pilgrim’s as global chief financial officer, effective March 15. He will report to Pilgrim’s president and global chief executive officer Fabio Sandri.Galvanoni served as vice president, finance at Ingredion Incorporated since 2016, managing all financial-related responsibilities for the $4 billion North American division of the Fortune 500 global manufacturing company. He joined Ingredion in 2012, serving in the role of global corporate controller and chief accounting officer, where he managed the company’s accounting-related and external financial reporting responsibilities.“We are excited...

Day: February 10, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice